H.R. 2058, recently introduced in May 2015 by U.S. Rep. Tom Cole, R-Okla., draws the attention of policymakers to the structure of the Food and Drug Administration’s regulatory regime for tobacco products. One must ask if the process truly is designed to protect public health or if it is instead designed to protect the sales and profits of the major “Big Tobacco” cigarette companies.
UPDATE: The bill number in this report has been changed to reflect recent legislative action. H.R. 4371, the Article I Consolidated Appropriations Amendments of 2016, has been superseded by other legislation.